Metabolomics of Bladder Cancer

Dr. Vishwajeet Singh is a well-known Urology professor who specializes in Uro-Oncology, Female Urology (Urogynecology), and Renal Transplantation. He currently works at King George's Medical University in Lucknow, Uttar Pradesh, India. Dr. Singh has made important contributions to the field of Urology through his research and publications. Uro-Oncology, Female Urology (Urogynecology), and Renal Transplantation are among his primary research interests. He has published multiple research papers in renowned journals over the previous ten years, demonstrating his skill and dedication to expanding knowledge in his profession. Mukul Kumar Singh is a Ph.D. Scholar and early career researcher at King George's Medical University's Department of Urology. He is actively researching the molecular mechanisms underlying immunotherapy failure in bladder cancer under the supervision of Dr. V. Singh. His research focuses on tumour metabolite change and proliferative mechanisms. He published several articles and book chapters on immunotherapeutic strategies and is a member of the European Association for Cancer Research (EACR), the American Society for Clinical Oncology (ASCO), the European Society for Medical Oncology (ESMO), and the Agricultural Technology Development Society (ATDS)

1. Contribution of Metabolomics in the Discovery of Biomarker for Bladder cancer
2. Role of Tobacco on Bladder Cancer Pathways
3. Regulation of Glycolysis in Bladder Cancer
4. Metabolism of Fatty Acid
5. Regulation of Pentose Phosphate Pathway
6. Mitochondrial Metabolism
7. Metabolic Effect of Cancer Therapy
8. Metabolomics and Racial Disparities in Bladder Cancer Carcinogensis